Clinical Characterization of FGFR-Altered Pediatric Low-Grade Gliomas
{{output}}
Pediatric low-grade gliomas (pLGG) are the predominant childhood central nervous system tumors. While BRAF alterations are known to drive the majority of pLGGs, a subgroup contains activating mutations or fusions involving FGFR1/2/3. FGFR is a receptor tyrosin... ...
